Abstract
Background: This study evaluates the cost-effectiveness of the DAZT program for scaling up treatment of acute child diarrhea in Gujarat India using a net-benefit regression framework. Methods: Costs were calculated from societal and caregivers' perspectives and effectiveness was assessed in terms of coverage of zinc and both zinc and Oral Rehydration Salt. Regression models were tested in simple linear regression, with a specified set of covariates, and with a specified set of covariates and interaction terms using linear regression with endogenous treatment effects was used as the reference case. Results: The DAZT program was cost-effective with over 95% certainty above $5.50 and $7.50 per appropriately treated child in the unadjusted and adjusted models respectively, with specifications including interaction terms being cost-effective with 85-97% certainty. Discussion: Findings from this study should be combined with other evidence when considering decisions to scale up programs such as the DAZT program to promote the use of ORS and zinc to treat child diarrhea.
| Original language | English (US) |
|---|---|
| Article number | 9 |
| Journal | Cost Effectiveness and Resource Allocation |
| Volume | 15 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jun 8 2017 |
Fingerprint
Keywords
- Cost-effectiveness
- Developing countries
- Diarrhea
- Implementation science
- India
- Net-benefit regression
- Oral rehydration salts
- Zinc
ASJC Scopus subject areas
- Health Policy
Cite this
Cost-effectiveness analysis of the diarrhea alleviation through zinc and oral rehydration therapy (DAZT) program in rural Gujarat India : An application of the net-benefit regression framework. / Shillcutt, Samuel D.; Lefevre, Amnesty E; Fischer-Walker, Christa L.; Taneja, Sunita; Black, Robert E; Mazumder, Sarmila.
In: Cost Effectiveness and Resource Allocation, Vol. 15, No. 1, 9, 08.06.2017.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Cost-effectiveness analysis of the diarrhea alleviation through zinc and oral rehydration therapy (DAZT) program in rural Gujarat India
T2 - An application of the net-benefit regression framework
AU - Shillcutt, Samuel D.
AU - Lefevre, Amnesty E
AU - Fischer-Walker, Christa L.
AU - Taneja, Sunita
AU - Black, Robert E
AU - Mazumder, Sarmila
PY - 2017/6/8
Y1 - 2017/6/8
N2 - Background: This study evaluates the cost-effectiveness of the DAZT program for scaling up treatment of acute child diarrhea in Gujarat India using a net-benefit regression framework. Methods: Costs were calculated from societal and caregivers' perspectives and effectiveness was assessed in terms of coverage of zinc and both zinc and Oral Rehydration Salt. Regression models were tested in simple linear regression, with a specified set of covariates, and with a specified set of covariates and interaction terms using linear regression with endogenous treatment effects was used as the reference case. Results: The DAZT program was cost-effective with over 95% certainty above $5.50 and $7.50 per appropriately treated child in the unadjusted and adjusted models respectively, with specifications including interaction terms being cost-effective with 85-97% certainty. Discussion: Findings from this study should be combined with other evidence when considering decisions to scale up programs such as the DAZT program to promote the use of ORS and zinc to treat child diarrhea.
AB - Background: This study evaluates the cost-effectiveness of the DAZT program for scaling up treatment of acute child diarrhea in Gujarat India using a net-benefit regression framework. Methods: Costs were calculated from societal and caregivers' perspectives and effectiveness was assessed in terms of coverage of zinc and both zinc and Oral Rehydration Salt. Regression models were tested in simple linear regression, with a specified set of covariates, and with a specified set of covariates and interaction terms using linear regression with endogenous treatment effects was used as the reference case. Results: The DAZT program was cost-effective with over 95% certainty above $5.50 and $7.50 per appropriately treated child in the unadjusted and adjusted models respectively, with specifications including interaction terms being cost-effective with 85-97% certainty. Discussion: Findings from this study should be combined with other evidence when considering decisions to scale up programs such as the DAZT program to promote the use of ORS and zinc to treat child diarrhea.
KW - Cost-effectiveness
KW - Developing countries
KW - Diarrhea
KW - Implementation science
KW - India
KW - Net-benefit regression
KW - Oral rehydration salts
KW - Zinc
UR - http://www.scopus.com/inward/record.url?scp=85020392252&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85020392252&partnerID=8YFLogxK
U2 - 10.1186/s12962-017-0070-y
DO - 10.1186/s12962-017-0070-y
M3 - Article
C2 - 28603456
AN - SCOPUS:85020392252
VL - 15
JO - Cost Effectiveness and Resource Allocation
JF - Cost Effectiveness and Resource Allocation
SN - 1478-7547
IS - 1
M1 - 9
ER -